KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TherapeuticsMD (TXMD) Return on Equity (2016 - 2025)

Historic Return on Equity for TherapeuticsMD (TXMD) over the last 13 years, with Q3 2025 value amounting to 0.01%.

  • TherapeuticsMD's Return on Equity fell 200.0% to 0.01% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.01%, marking a year-over-year decrease of 200.0%. This contributed to the annual value of 0.0% for FY2024, which is 800.0% up from last year.
  • According to the latest figures from Q3 2025, TherapeuticsMD's Return on Equity is 0.01%, which was down 200.0% from 0.0% recorded in Q2 2025.
  • Over the past 5 years, TherapeuticsMD's Return on Equity peaked at 5.35% during Q2 2021, and registered a low of 16.9% during Q4 2022.
  • For the 5-year period, TherapeuticsMD's Return on Equity averaged around 0.19%, with its median value being 0.01% (2025).
  • In the last 5 years, TherapeuticsMD's Return on Equity plummeted by -179500bps in 2022 and then surged by 168100bps in 2023.
  • TherapeuticsMD's Return on Equity (Quarter) stood at 1.05% in 2021, then crashed by -1709bps to 16.9% in 2022, then skyrocketed by 99bps to 0.09% in 2023, then skyrocketed by 105bps to 0.0% in 2024, then skyrocketed by 74bps to 0.01% in 2025.
  • Its Return on Equity was 0.01% in Q3 2025, compared to 0.0% in Q2 2025 and 0.0% in Q1 2025.